Literature DB >> 6770044

Influence of the H2-receptor blocking agent metiamide on the clonidine-induced changes in the brain catecholamine turnover.

N E Andén, M Grabowska-Andén.   

Abstract

Metiamide (800 micrograms intracerebroventricularly to rats) enhanced the DOPA accumulation in noradrenaline-predominant brain areas following DOPA decarboxylase inhibition and it accelerated the alpha-methyltyrosine-induced disappearance of noradrenaline in the brain, both normally and after clonidine (0.1 mg/kg i.p.). These findings indicate that metiamide stimulates the release of noradrenaline. They can explain why metiamide antagonizes the clonidine-induced hypotension.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770044     DOI: 10.1007/bf01250599

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  19 in total

1.  Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidine.

Authors:  H Karppanen; I Paakkari; P Paakkari; R Huotari; A L Orma
Journal:  Nature       Date:  1976-02-19       Impact factor: 49.962

2.  Clonidine-induced hypotension: further evidence for a central interaction with histamine H2 receptor antagonists in the rat.

Authors:  L Finch; C A Harvey; P E Hicks; D A Owen
Journal:  Neuropharmacology       Date:  1978 Apr-May       Impact factor: 5.250

3.  Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.

Authors:  M Grabowska; N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

5.  An interaction of histamine H2-receptor antagonists with the noradrenergic system in rat brain.

Authors:  J Z Nowak; A Pilc; C Maśliński
Journal:  Eur J Pharmacol       Date:  1978-09-01       Impact factor: 4.432

6.  Evidence for a central noradrenaline receptor stimulation by clonidine.

Authors:  N E Andén; H Corrodi; K Fuxe; B Hökfelt; T Hökfelt; C Rydin; T Svensson
Journal:  Life Sci       Date:  1970-05-01       Impact factor: 5.037

7.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

8.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.

Authors:  H Schmitt; S Fénard
Journal:  Arzneimittelforschung       Date:  1973-01

9.  Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.

Authors:  H Corrodi; K Fuxe; T Hökfelt
Journal:  Life Sci       Date:  1966-04       Impact factor: 5.037

10.  Further evidence for central histamine H2-receptor involvement in the hypotensive effect of clonidine in the rat.

Authors:  H Karppanen; I Paakkari; P Paakkari
Journal:  Eur J Pharmacol       Date:  1977-04-07       Impact factor: 4.432

View more
  1 in total

1.  In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus.

Authors:  A Philippu; M Bald; A Kraus; H Dietl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.